The page is the record's research on the issuer — no analyst, no rating, no view. # Keros Therapeutics, Inc. (NASDAQ: KROS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Keros Therapeutics, Inc., listed on NASDAQ under ticker KROS, with ISIN US4923271013. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US). Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its status is listed, not halted. The segment and jurisdiction are not on the record. ## The disclosure read The record holds 88 filings across 49 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 5.0 days. The latest filing is dated 2026-11-05, is of type corporate_news, and falls 3 days before the record date. The NASDAQ median is 6.0 days cadence, 52 filings and 5.0 days latency across 4,359 issuers. The sector median is 6.0 days cadence, 63.0 filings and 4.0 days latency across 526 issuers. ## Auditor The auditor of record is Deloitte & Touche LLP, located in Boston, MA. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001664710.json (identity.name) - https://mcp.us-cm-kg.ai/events/NASDAQ/KROS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1664710/000166471026000018/kros-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/KROS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/KROS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp